Bayer and Monsanto announced that they signed a definitive merger agreement under which Bayer will acquire Monsanto for $128 per share in an all-cash transaction. Monsanto's Board of Directors, Bayer's Board of Management and Bayer's Supervisory Board have unanimously approved the agreement. The offer represents a premium of 44% to Monsanto's closing share price on May 9, 2016, the day before Bayer's first written proposal to Monsanto.
Morrow Sodali is serving as the proxy solicitor for Monsanto.
Related News
New Diligent Market Intelligence report finds fewer proxy fights, more negotiated boardroom gains and longer settlement timelines in the first half of 2026
30 July 2026
Proxy Advisory Firms Are Here to Stay, but Their Role Is Changing
28 July 2026
Measurabl Expands Partner Network with Six Leading Service Providers as New Members
16 July 2026
Sodali & Co Recognized Among Top Global Advisers in Bloomberg's H1 2026 Activism League Tables
08 July 2026
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right